Recombinant LAG3 (Relatlimab Biosimilar) antibody

Catalog No. ABIN7093078

The Human Monoclonal anti-LAG3 (Relatlimab Biosimilar) antibody has been validated for ELISA and FACS. It is suitable to detect LAG3 (Relatlimab Biosimilar) in samples from Human.

Quick Overview for Recombinant LAG3 (Relatlimab Biosimilar) antibody (ABIN7093078)

Target: LAG3 (Relatlimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This LAG3 (Relatlimab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-LAG3 (Relatlimab Biosimilar) Antibody

Purpose: Anti-LAG3 (relatlimab biosimilar)mAb

Characteristics: LAG-3,CD223

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG4

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for LAG3 (Relatlimab Biosimilar)

Target: LAG3 (Relatlimab Biosimilar)

Background: Synonyms: BMS-986016,ONO-4482

Gene ID: 3902

UniProt: P18627